🔥 Breakout ↑ Rising
Health
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs
Employers are resisting the expansion of insurance coverage for high-cost GLP-1 obesity medications.
2 trends tracked about this subject — the full history, oldest to newest below.
Employers are resisting the expansion of insurance coverage for high-cost GLP-1 obesity medications.
Goldman Sachs and Morgan Stanley join employer matching programs as Trump Accounts launch on July 4, 2026.